Sarcopenia

AKRON, Ohio, August 18, 2026 Resivant Medical announced the successful completion of the first patient cases using its Cutiva™...

VAN NUYS, Calif., August 18, 2026 Kandu, Inc. announced the publication of results from BCI-REHAB, the first randomized controlled...

CARLSBAD, Calif., August 18, 2026 ImpediMed announced that the U.S. Food and Drug Administration (FDA) has granted 510(k) clearance...

NMD Pharma, Aarhus, Denmark, July 23, 2026 NMD Pharma has announced the publication of groundbreaking clinical and preclinical research...

HOUSTON, Texas, June 5, 2026 Eos SENOLYTIX, Inc. presented new preclinical findings for its lead MitoXcel™ geropeptide candidate PTC-2105...